Absci Corporation (ABSI) has a MoatMap StockRank of 48/100 based on Quality (28/100), Value (33/100), and Momentum (74/100) factor scores. The current signal is HOLD. Early-stage AI drug discovery platform with high cash burn and no proven path to profitability, failing our quality compounder criteria.
Absci Corporation is an AI-powered drug discovery company that utilizes its 'wet lab + dry lab' platform to discover novel biotherapeutics and accelerate drug development. It integrates generative AI with high-throughput experimental biology to design, validate, and manufacture new biologics faster and more effectively than traditional methods. The company is revolutionizing the biopharmaceutical discovery process by leveraging advanced AI and synthetic biology.
| Price | $6.83 |
| Market Cap | $948M |
| P/E (Forward) | -11.40 |
| Price/Book | 6.63 |
| Return on Equity | -63.9% |
| Return on Invested Capital | -59.4% |
| Debt/Equity | 2.57 |
| Gross Margin | 0.0% |
| Operating Margin | -14347.0% |
| Revenue Growth | -81.8% |
| Free Cash Flow | $-41M |
Absci Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).